The University of Chicago Header Logo

Connection

Dejan Micic to C-Reactive Protein

This is a "connection" page, showing publications Dejan Micic has written about C-Reactive Protein.
Connection Strength

0.036
  1. Vedolizumab as Induction and Maintenance for Inflammatory Bowel Disease: 12-month Effectiveness and Safety. Inflamm Bowel Dis. 2018 03 19; 24(4):849-860.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.